Patient misconceptions and ethical challenges in radioactive iodine scanning and therapy

Journal of Nuclear Medicine Technology

Volumn 34, Issue 3, 2006, Pages 143-150

  Rosenthal, M Sara ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Bioethics; Ethical challenges; Informed consent; Patient misconceptions; Radioactive iodine; Thyroid

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE; STEROID; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BIOETHICS; CANCER RISK; CATHETER ABLATION; GRAVES DISEASE; HEALTH PROMOTION; HUMAN; HYPOTHYROIDISM; INFORMED CONSENT; MEDICAL PRACTICE; PATIENT CARE; PATIENT EDUCATION; PATIENT PARTICIPATION; PHYSICIAN ATTITUDE; SCINTISCANNING; THYROID CANCER; THYROID DISEASE; TREATMENT PLANNING; ATTITUDE TO HEALTH; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOCTOR PATIENT RELATION; ETHICS; RADIOTHERAPY; REVIEW; UNITED STATES;

ATTITUDE TO HEALTH; INFORMED CONSENT; IODINE RADIOISOTOPES; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; RADIOPHARMACEUTICALS; RADIOTHERAPY; TOMOGRAPHY, EMISSION-COMPUTED; UNITED STATES;

EID: 34250653235     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Ain K. Management of thyroid cancer. In: Braverman L, ed. Diseases of the Thyroid. Vol 2. Totowa, NJ: Humana Press; 1997:287.
2. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am. 1997;26:777-800.
3. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA. 1995;273:808-812.
4. 131I. In: Medeiros-Neto G, Gaitan E, eds. Frontiers in Thyroidology. Vol 2. New York, NY: Plenum Medical Book Co.; 1986:1317-1321.
5. Hesse BW, Nelson DE, Kreps GL, et al. Trust and sources of health information: the impact of the Internet and its implications for health care providers - findings from the first Health Information National Trends Survey. Arch Intern Med. 2005;165:2618-2624.
6. George J, Patterson NH. Graves' Disease: In Our Own Words. Fleming Island, FL: National Graves' Disease Foundation; 2002:vii-7.
7. Abraham-Nordling M, Torring O, Hamberger B, et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery. Thyroid. 2005;15:1279-1286.
8. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res. 2006;37:133-139.
9. Shomon M. Living Well with Hypothyroidism. New York, NY: Avon Books; 2000.
10. Moore E, Moore L. Graves' Disease: a Practical Guide. Jefferson, NC: McFariand & Co.; 2001.
11. Flax K. Healing Options: A Report on Graves' Disease Treatments. 2nd ed. Sparkill, NY: Sally Breer; 2001.
12. Veatch RM. Abandoning informed consent. Hastings Cent Rep. 1995;25:5-12.
13. The International League of Atomic Women. Available at: http://www.geocities. com/ibayoa/cancerafter.html. Accessed December 19, 2005.
14. Gofman J. Preventing Breast Cancer: The Story of a Major, Proven, Preventable Cause of This Disease. San Francisco, CA: CNR Book Division, Committee for Nuclear Responsibility; 1995.
15. Website of author Elaine Moore. Available at: www.elainemoore.com. Accessed December 19, 2005.
16. Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA. 1998;280:347-355.
17. Bartalena L, Marcocci C, Bogazzi F, et al. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med. 1998;338:73-78.
18. Petros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J. A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab. 2005;9: 5321-5323.
19. Wartofsky L, Glinoer D, Solomon B, et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States. Thyroid. 1991;1:129-135.
20. 131I therapy for Graves' disease: case selection and restrictions recommended to patients in Japan, Korea, and China. Thyroid. 1997;7:217-220.
21. Romaldini JH. Case selection and restrictions recommended to patients with hyperthyroidism in South America. Thyroid. 1997;7:225-228.
22. Walsh JP. Management of Graves' disease in Australia. Aust N Z J Med. 2000;30:559-566.
23. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002;110(suppl 3):349-353.
24. A website/blog of a thyroid patient. Available at: www. notovertillthefatladysings. com. Accessed December 19, 2005.
25. Razvi S, McMillan CV, Weaver JU. Instruments used in measuring symptoms, health status and quality of life in hypothyroidism: a systematic qualitative review. Clin Endocrinol (Oxf). 2005;63:617-624.
26. Barnes BO, Galton L. Hypothyroidism: The Unsuspected Illness. Trumbull, CT: Broda O. Barnes Research Foundation, Inc.; 1976.
27. Arem R. The Thyroid Solution. New York, NY: Random House; 1999.
28. Dralle H, Sekulla C. Morbidity after subtotal and total thyroidectomy in patients with Graves' disease: the basis for decision-making regarding surgical indication and extent of resection [in German]. Z Arztl Fortbild Qualitatssich. 2004; 98(suppl 5):45-53.
29. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998;338:297-306.
30. Vassilopoulou-Sellin R, Palmer L, Taylor S, Cooksley CS. Incidence of breast carcinoma in women with thyroid carcinoma. Cancer. 1999;85:696-705.
31. National Assessment of Adult Literacy (NAAL). A First Look at the Literacy of America's Adults in the 21st Century. Washington, DC: National Center for Education Statistics (NCES); 2005.
32. Ain K. What is the low iodine diet and why do you need it? In: Gilletz N, ed. The Low Iodine Diet Cookbook. Toronto, Ontario, Canada: Your Health Press; 2005:5-18.
33. Beauchamp TL, Childress J. Principles of Biomedical Ethics. 4th ed. New York, NY: Oxford University Press; 1994.
34. Rosenthal MS, Pierce HH. Inherited medullary thyroid cancer and the duty to warn: revisiting Pate v. Threlkel in light of HIPAA. Thyroid. 2005;15: 140-145.
35. McCullough LB, Chervenak F. Ethics in Obstetrics and Gynecology. London, U.K.: Oxford University Press; 1994:139-140.
36. Etchells E, Sharpe G, Burgess M, Singer PA. Consent. CMAJ. 1996;155: 177-180.
37. Etchells E, Sharpe G, Burgess M, Singer PA. Disclosure. CMAJ. 1996;155: 387-391.
38. Geffner DL, Hershman JM. Beta-adrenergic blockade for the treatment of hyperthyroidism. Am J Med. 1992;93:61-68.
39. Tagay S, Herpertz S, Langkafel M, et al. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endocrinol. 2005;153:755-763.
40. Kaplan M, Sarne DH, Schneider AB. In search of the impossible dream? Thyroid hormone replacement therapy that treats all symptoms in hypothyroid patients. J Clin Endocrinol Metab. 2003;88:4540-4542.
41. Etchells E, Sharpe G, Burgess M, Singer PA. Voluntariness. CMAJ. 1996;155: 1083-1086.
42. Kaufert JM, Putsch RW. Communication through interpreters in healthcare: ethical dilemmas arising from differences in class, culture, language and power. J Clin Ethics. 1996;8:71-87.